In the third episode of our second season, we spoke with Dr. Ankit Mahadevia, CEO of Spero Therapeutics and former Venture Partner at Atlas Venture. Our conversation focused on the benefits of diverse exposure within the healthcare ecosystem, unique challenges of developing antibiotics, and leadership lessons learned through a prolonged career company creation.

Spero Therapeutics is a public company focused on developing next-generation antibiotics for infectious diseases based in Cambridge, MA.